{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:12:31Z","timestamp":1760659951113,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[1992]]},"DOI":"10.1016\/s0952-7915(06)80037-3","type":"journal-article","created":{"date-parts":[[2007,8,24]],"date-time":"2007-08-24T08:05:43Z","timestamp":1187942743000},"page":"449-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Synthetic peptides as vaccines"],"prefix":"10.1016","volume":"4","author":[{"given":"Ruth","family":"Arnon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0952-7915(06)80037-3_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0167-5699(87)90239-8","article-title":"Synthetic Peptides: a Next Generation of Vaccines?","volume":"8","author":"Steward","year":"1987","journal-title":"Immunol Today"},{"key":"10.1016\/S0952-7915(06)80037-3_bib2","first-page":"67","article-title":"The Potential of Peptides as Vaccines","volume":"1","author":"Brown","year":"1990"},{"key":"10.1016\/S0952-7915(06)80037-3_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/eji.1830210128","article-title":"Parameters Affecting the Immunogenicity of a Liposome-associated Synthetic Hexapeptide Antigen","volume":"21","author":"Frisch","year":"1991","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0952-7915(06)80037-3_bib4","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.4049\/jimmunol.146.11.3697","article-title":"Universal Vaccine Carrier: Liposomes that Provide T-dependent Help to Weak Antigens","volume":"146","author":"Garcon","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(06)80037-3_bib5_1","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/eji.1830211102","article-title":"Efficiency of Peptides and Lipopeptides for In-vivo Priming of Virus-specific Cytotoxic T Cells","volume":"21","author":"Schild","year":"1991","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0952-7915(06)80037-3_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4049\/jimmunol.147.2.410","article-title":"Role of Intrastructural\/Intermolecular Help in Immunization with Peptide-phospholipid Complexes","volume":"147","author":"Goodman-Snitkoff","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(06)80037-3_bib7","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/eji.1830211002","article-title":"Mycobacterial Heat-shock Proteins as Carrier Molecules","volume":"21","author":"Lussow","year":"1991","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0952-7915(06)80037-3_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4049\/jimmunol.146.3.793","article-title":"TraT: a Powerful Carrier Molecule for the Stimulation of Immune Responses to Protein and Peptide Antigens","volume":"146","author":"Croft","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(06)80037-3_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0161-5890(91)90073-S","article-title":"Rotavirus Particles Function as Immunological Carriers for the Delivery of Peptides from Infectious Agents and Endogenous Proteins","volume":"28","author":"Redmond","year":"1991","journal-title":"Mol Immunol"},{"key":"10.1016\/S0952-7915(06)80037-3_bib10","first-page":"5409","article-title":"Synthetic Peptide Vaccine Design: Synthesis and Properties of a High-density Multiple Antigenic Peptide System","volume":"28","author":"Tam","year":"1988"},{"key":"10.1016\/S0952-7915(06)80037-3_bib11","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1084\/jem.157.6.1947","article-title":"Circumsporozoite Proteins of Malaria Parasites Contain a Single Immunodominant Region with Two or More Identical Epitopes","volume":"157","author":"Zavala","year":"1983","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(06)80037-3_bib12_1","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/eji.1830210941","article-title":"Lack of H-2 Restriction of the Plasmodium falciparum (NANP) Sequence as Multiple Antigen Peptide","volume":"21","author":"Pessi","year":"1991","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0952-7915(06)80037-3_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4049\/jimmunol.148.1.208","article-title":"Protective Immunization with Invariant Peptides of the Plasmodium falciparum Antigen MSA2","volume":"148","author":"Saul","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(06)80037-3_bib14_1","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.4049\/jimmunol.146.6.1987","article-title":"Antigenicity and Immunogenicity of a Multiple Peptidic Construction of the Schistosoma mansoni SM-28 GST Antigen in Rat. Mouse, and Monkey. I. Partial Protection of Fischer Rat after Active Immunization","volume":"146","author":"Wolowczuk","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(06)80037-3_bib15","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/353852a0","article-title":"Precise Prediction of a Dominant Class I MHC-restricted Epitope of Listeria Monocytogenes","volume":"353","author":"Pamer","year":"1991","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(06)80037-3_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/351290a0","article-title":"Allele-specific Motifs Revealed by Sequencing fo Self-peptides Eluted from MHC Molecules","volume":"351","author":"Falk","year":"1991","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(06)80037-3_bib17","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/j.1460-2075.1984.tb02226.x","article-title":"Neutralization of Heat-labile Toxin of E. coli by Antibodies to Synthetic Peptides Derived from the B Subunit of Cholera Toxin","volume":"3","author":"Jacob","year":"1984","journal-title":"EMBO J"},{"key":"10.1016\/S0952-7915(06)80037-3_bib18","series-title":"New Generation Vaccines","first-page":"688","article-title":"Synthetic Peptide Toxoid Vaccines against Shiga Dysentery","author":"Arnon","year":"1990"},{"key":"10.1016\/S0952-7915(06)80037-3_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-2478(89)90053-9","article-title":"Expression of Shiga Toxin Epitopes in E. coli Immunological Characterization","volume":"21","author":"McEwen","year":"1989","journal-title":"Immunol Lett"},{"key":"10.1016\/S0952-7915(06)80037-3_bib20_1","first-page":"2283","article-title":"Protection against Lethal Sendai Virus Infection by in Vivo Priming of Virusspecific Cytotoxic T Lymphocytes with a Free Synthetic Peptide","volume":"88","author":"Kast","year":"1991"},{"key":"10.1016\/S0952-7915(06)80037-3_bib21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1099\/0022-1317-72-3-557","article-title":"Identification of Linear Epitopes on Semliki Forest Virus E2 Membrane and Their Effectiveness as a Synthetic Peptide Vaccine","volume":"72","author":"Snijders","year":"1991","journal-title":"J Gen Virol"},{"key":"10.1016\/S0952-7915(06)80037-3_bib22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0042-6822(90)90318-L","article-title":"Virus Envelope-based peptide Vaccines against Virus-induced Mammary Tumors","volume":"179","author":"Dion","year":"1990","journal-title":"Virology"},{"key":"10.1016\/S0952-7915(06)80037-3_bib23_1","first-page":"991","article-title":"Peptide-induced Antiviral Protection by Cytotoxic T cells","volume":"88","author":"Schuiz","year":"1991"},{"key":"10.1016\/S0952-7915(06)80037-3_bib24_1","first-page":"249","article-title":"Immunological Evaluation of the Multiple Antigen Peptide (MAP) System Using the Major Immunogenic Site of Foot-and-Mouth Disease Virus","volume":"73","author":"Francis","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/S0952-7915(06)80037-3_bib25","first-page":"99","article-title":"High-affinity Antibody Induced by Immunization with a Synthetic Peptide is Associated with Protection of Cattle against Foot-and-Mouth Disease","volume":"72","author":"Steward","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/S0952-7915(06)80037-3_bib26","series-title":"Synthetic Vaccines","article-title":"Influenza","author":"Horwitz","year":"1992"},{"key":"10.1016\/S0952-7915(06)80037-3_bib27","first-page":"569","article-title":"Anti-influenza Response Achieved by Immunization with a Synthetic Antigen","volume":"79","author":"Muller","year":"1982"},{"key":"10.1016\/S0952-7915(06)80037-3_bib28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/342561a0","article-title":"In Vivo Priming of Virus-specific Cytotoxic T Lymphocytes with Synthetic Lipopeptide Vaccine","volume":"342","author":"Deres","year":"1989","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(06)80037-3_bib29","first-page":"24","article-title":"In Hot Pursuit of an HIV Vaccine","volume":"10","author":"Spaiding","year":"1992","journal-title":"Biotechnology"},{"key":"10.1016\/S0952-7915(06)80037-3_bib30","first-page":"3105","article-title":"An Immunodominant Epitope of the Human Immunodeficiency Virus Envelope Glycoprotein gp160 Recognized by Class I Major Histocompatibility Complex Molecule-restricted Murine Cytotoxic T Lymphocytes","volume":"85","author":"Takahashi","year":"1988"},{"key":"10.1016\/S0952-7915(06)80037-3_bib31","doi-asserted-by":"crossref","first-page":"914","DOI":"10.4049\/jimmunol.148.3.914","article-title":"A Chemically Defined Synthetic Vaccine Model for HIV-1","volume":"148","author":"Nardelli","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(06)80037-3_bib32","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1126\/science.1703322","article-title":"Broadly Neutralizing Antibodies Elicited by the Hypervariable Neutralizing Determinant of HIV-01","volume":"250","author":"Javaherian","year":"1990","journal-title":"Science"},{"key":"10.1016\/S0952-7915(06)80037-3_bib33","first-page":"6800","article-title":"Prediction of Optimal Peptide Mixtures to Induce Broadly Neutralizing Antibodies to Human Immunodeficiency Virus Type 1","volume":"88","author":"Holley","year":"1991"},{"key":"10.1016\/S0952-7915(06)80037-3_bib34_1","first-page":"9449","article-title":"Priming of Anti-human Immunodeficiency Virus (HIV) CD8+ Cytotoxic T Cells in Vivo by Carrier-free HIV synthetic Peptides","volume":"88","author":"Hart","year":"1991"},{"key":"10.1016\/S0952-7915(06)80037-3_bib35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1126\/science.1372448","article-title":"Induction of Broadly Cross-reactive Cytotoxic T Cells Recognizing an HIV-1 Envelope Determinant","volume":"255","author":"Takahashi","year":"1992","journal-title":"Science"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791506800373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791506800373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:19:59Z","timestamp":1760602799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791506800373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1992]]}},"alternative-id":["S0952791506800373"],"URL":"https:\/\/doi.org\/10.1016\/s0952-7915(06)80037-3","relation":{},"ISSN":["0952-7915"],"issn-type":[{"type":"print","value":"0952-7915"}],"subject":[],"published":{"date-parts":[[1992]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic peptides as vaccines","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0952-7915(06)80037-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1992 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}